Skip to main content

Exosomes clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • ExoLuminate Study for Early Detection of Pancreatic Cancer

    open to eligible people ages 18 years and up

    ExoLuminate is a nationally-enrolling registry study designed for earlier detection of cancer in patients at elevated risk or clinically-suspicious for pancreatic ductal adenocarcinoma (PDAC). Those with elevated risk for PDAC can include individuals with intraductal papillary mucinous neoplasms, family history of pancreatic cancer, germline mutations in genes known to be associated with cancer, and a personal or family history of pancreatitis. The goal of the study is to compare the performance of ExoVerita™ assay in early detection of PDAC to current standard-of-care methods of surveillance.

    at UCSD

Last updated: